单患者使用心电图电缆和导联系统在冠状动脉旁路移植术监测中的成本效益数据表1

数据集获取（Figshare）

• 源站标题：Data_Sheet_1_The Cost Effectiveness of Single-Patient-Use Electrocardiograph Cable and Lead Systems in Monitoring for Coronary Artery Bypass Graft Surgery.docx
• DOI：10.3389/fcvm.2019.00061.s001
• 发布日期：2019-05-10
• 文件数：1 个
• 文件总体积：48.36 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_The_Cost_Effectiveness_of_Single-Patient-Use_Electrocardiograph_Cable_and_Lead_Systems_in_Monitoring_for_Coronary_Artery_Bypass_Graft_Surgery_docx/8108063

命令行下载

curl -L -o "Data_Sheet_1_The Cost Effectiveness of Single-Patient-Use Electrocardiograph Cable and Lead Systems in Monitoring for Coronary Artery Bypass Graft Sur.docx" "https://ndownloader.figshare.com/files/15122531"

文件清单

• Data_Sheet_1_The Cost Effectiveness of Single-Patient-Use Electrocardiograph Cable and Lead Systems in Monitoring for Coronary Artery Bypass Graft Sur.docx（48.36 KB）

文件总体积 48.36 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background: During admission for coronary artery bypass graft (CABG) surgery patients receive electrocardiograph (ECG) monitoring; for which reusable ECG cable and leads (rECG) are standard.
Objective: Evaluate the cost effectiveness of a single-patient-use ECG cable and lead system (spECG).
Methods: Review of the Medicare 2011–2014 database followed by a cost-effectiveness model considering a Medicare facility transitioning from rECG ($9 per patient) to spECG ($15). In-hospital ECG monitoring was for ≤8 days. In the model, patients underwent CABG and recovered in the intensive care unit, before transfer to the general ward and discharge. Surgical site infection (SSI) resulted in increased length of stay, readmission, or outpatient care. Health outcomes impacted EQ-5D-measured quality adjusted life years (QALYs). Health and cost outcomes were discounted at 3.5% annually. All costs in 2016 USD. Significance (95% level) was assessed via 2,000 simulations.
Results: In 2014, 5.49% of patients had an SSI by 90-days post-surgery, with spECG reducing the odds of an SSI (odds ratio: 0.74, 0.62–0.89). Mean 40-year, per-patient costs to Medicare were $65,497 with rECG and $65,048 with spECG. The $450 saving was significant, with a median (95% credible interval) reduction of $466 ($174 to $989). Cost drivers were days required to treat inpatient SSIs. QALYs increases with spECG were significant but minor (median increase 0.008). Medicare savings may total $40 million per year with use of spECG.
Conclusions: Post-operative SSI is a concern for Medicare patients undergoing CABG, and use of spECG is likely to provide cost and patient benefits.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fcvm.2019.00061.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_The_Cost_Effectiveness_of_Single-Patient-Use_Electrocardiograph_Cable_and_Lead_Systems_in_Monitoring_for_Coronary_Artery_Bypass_Graft_Surgery_docx/8108063）。